Beijing Saisheng Pharmaceutical

Beijing Saisheng Pharmaceutical Co., Ltd. is a specialized pharmaceutical enterprise based in China, focusing on the research, development, and production of biochemical and biological medicines. The company primarily targets four therapeutic areas: cardiovascular and cerebrovascular diseases, immune system modulation, nervous system disorders, and digestive health. Its commercial portfolio includes high-tech biochemical products such as Thrombin for injection and Alprostadil. Listed on the Shenzhen Stock Exchange, the company actively expands its innovative drug pipeline through its proprietary R&D center and strategic industrial investments. Beijing Saisheng is committed to advancing medical outcomes through the development of recombinant proteins and novel small molecule therapies.